Chemoinformaics analysis of 2,3-Dimethylpyrazine
| Molecular Weight | 108.144 | nRot | 0 |
| Heavy Atom Molecular Weight | 100.08 | nRig | 6 |
| Exact Molecular Weight | 108.069 | nRing | 1 |
| Solubility: LogS | 0.847 | nHRing | 1 |
| Solubility: LogP | 0.715 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 17.5543 |
| nHD | 0 | BPOL | 10.3057 |
| QED | 0.497 |
| Synth | 2.271 |
| Natural Product Likeliness | -0.425 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.348 |
| MDCK | 0.0000344 |
| BBB | 0.766 |
| PPB | 0.244156 |
| VDSS | 1.621 |
| FU | 0.778189 |
| CYP1A2-inh | 0.101 |
| CYP1A2-sub | 0.492 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.69 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.506 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.776 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.218 |
| CL | 4.487 |
| T12 | 0.371 |
| hERG | 0.011 |
| Ames | 0.087 |
| ROA | 0.309 |
| SkinSen | 0.9 |
| Carcinogencity | 0.334 |
| EI | 0.995 |
| Respiratory | 0.784 |
| NR-Aromatase | 0.022 |
| Antiviral | No |
| Prediction | 0.905127 |